Access cutting-edge lupus treatment through this clinical trial at a research site in Oklahoma City. Study-provided care at no cost to qualified participants.
Access lupus specialists in Oklahoma City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lupus treatment provided free
Hydroxychloroquine (HCQ) is a systemic lupus erythematosus (SLE) medication that has been very effective in reducing lupus disease activity and keeping patients stable with reduced symptoms. Despite a track record of safety with regard to infection compared to traditional immunosuppressive agents, the risk of HCQ retinal toxicity escalates with continued use. Evaluation using sensitive standard of care approaches suggests nearly a third of patients accrue retinal damage. Data are needed to accur
Sponsor: NYU Langone Health
Check if you qualify for this lupus clinical trial in Oklahoma City, OK
If you're searching for lupus treatment options in Oklahoma City, OK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Oklahoma City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lupus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.